List of insiders holdings for Celularity Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | STARR INTERNATIONAL CO INC Starr International Investments Ltd. 10% Owner |
2023-02-13 17:13:31 | 15,281,389 0 |
15,281,389 | Form 13G |
| 2 | GX Sponsor LLC 10% Owner |
2021-07-20 21:34:58 | 14,187,500 0 |
14,187,500 | Form 4 |
| 3 | Lim Kok Thay Dragasac Ltd Genting Berhad 10% Owner |
2025-01-28 16:45:32 | 2,531 7,523,885 |
7,526,416 | Form 4 |
| 4 | Sorrento Therapeutics Inc. 10% Owner |
2023-10-05 17:22:14 | 5,050,427 0 |
5,050,427 | Form 13G |
| 5 | Resorts World Inc Pte. Ltd. 10% Owner |
2024-12-19 21:49:11 | 3,600,000 0 |
3,600,000 | Form 3 |
| 6 | Pecora Andrew L President |
2021-09-17 14:48:53 | 2,469,282 0 |
2,469,282 | Form 4 |
| 7 | Ling Geoffrey M.D. Director |
2025-01-06 21:51:24 | 1,402,162 0 |
1,402,162 | Form 4 |
| 8 | Kilcoyne Adrian Chief Medical Officer |
2024-02-21 21:38:15 | 1,327,451 0 |
1,327,451 | Form 4 |
| 9 | SCULLEY JOHN Director |
2023-06-16 21:01:18 | 1,282,438 0 |
1,282,438 | Form 4 |
| 10 | Parks Diane L. Director |
2025-01-07 16:05:29 | 666,006 0 |
666,006 | Form 4 |
| 11 | Kehler Dean C Director |
2025-01-06 16:54:31 | 666,006 0 |
666,006 | Form 4 |
| 12 | Diamandis Peter Director |
2025-03-03 16:30:19 | 618,182 0 |
618,182 | Form 4/A |
| 13 | VON ESCHENBACH ANDREW C. Director |
2023-06-16 21:02:25 | 613,844 0 |
613,844 | Form 4 |
| 14 | Mazur Marc Director |
2023-06-16 21:02:41 | 513,844 0 |
513,844 | Form 4 |
| 15 | Smith Robin L Director |
2023-06-16 21:02:47 | 513,844 0 |
513,844 | Form 4 |
| 16 | Glover Bradley See Remarks |
2023-04-17 21:12:44 | 351,192 0 |
351,192 | Form 4 |
| 17 | BERMAN RICHARD J Director |
2025-01-06 16:54:31 | 270,273 0 |
270,273 | Form 4 |
| 18 | Mirakhur Beloo EVP, Clinical Development |
2021-09-15 18:50:54 | 125,000 0 |
125,000 | Form 4 |
| 19 | Dunn Keary See Remarks |
2022-04-28 21:04:29 | 64,505 0 |
64,505 | Form 4 |
| 20 | Bloom Jay R Director |
2021-09-13 18:03:21 | 56,053 0 |
56,053 | Form 4 |
| 21 | Jones Anne Chief Business Officer |
2022-11-18 20:16:41 | 49,154 0 |
49,154 | Form 4 |
| 22 | Haines John R Senior Exec Vice President |
2025-04-15 16:30:26 | 30,762 0 |
30,762 | Form 4 |
| 23 | Hariri Robert J Chief Executive Officer |
2025-04-15 16:30:27 | 23,609 0 |
23,609 | Form 4 |
| 24 | Fletcher Kyle See Remarks |
2024-04-16 20:56:13 | 21,085 0 |
21,085 | Form 4 |
| 25 | Beers David C Chief Financial Officer |
2025-04-15 16:30:24 | 19,226 0 |
19,226 | Form 4 |
| 26 | Brigido Stephen Pres., Functional Regeneration |
2025-04-15 16:30:29 | 9,741 0 |
9,741 | Form 4 |
| 27 | Weinberger Hillel Director |
2019-05-20 21:40:12 | 0 0 |
0 | Form 3 |
| 28 | Maselli Michael G Vice President of Acquisitions |
2019-05-20 21:39:29 | 0 0 |
0 | Form 3 |
| 29 | LEVY PAUL S Director |
2019-05-20 21:39:04 | 0 0 |
0 | Form 3 |
| 30 | Kellett Andrea J. Chief Financial Officer |
2019-05-20 21:38:41 | 0 0 |
0 | Form 3 |